Embracing AI in oncology: A fireside chat with industry leaders at AACR 2024 - Tempus

06/25/2024

Embracing AI in oncology: A fireside chat with industry leaders at AACR 2024

Industry leaders highlight the importance of multimodal data, AI-driven diagnostics, and the necessity of innovative approaches to meet the challenges of oncology treatment.

Authors Iker Huerga
EVP, Life Science Strategy and Real World Data, Tempus

Cristian Massacesi
Chief Medical Officer and Chief Development Officer for Oncology, AstraZeneca

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Related Content

View more

04/02/2025

Development of a clinical algorithm to prognosticate response to immunotherapy

Discover how Tempus developed and deployed the Immune Profile Score (IPS)—a powerful algorithm that provides prognostic insights into patient outcomes following treatment with immune checkpoint inhibitors (ICIs)—in ~18 months. This case study highlights the AI-driven methodology, real-world validation, and the impact of IPS in precision oncology.
Read more
03/25/2025

AI & ML in action: Unlocking RWD with GenAI through Tempus Lens

Discover how Tempus is equipping researchers with innovative AI solutions to fully leverage the potential of multimodal data. Gain insights from a panel of leaders across healthcare and life sciences as they discuss the impact of these advanced tools on delivering insights with speed.

Secure your recording now.
Watch replay
03/11/2025

Case Report: Pharmacogenomic testing and mood stabilizers

This real-world case demonstrates how the Tempus nP pharmacogenomic test facilitated a personalized treatment approach for a patient with bipolar disorder.
Read more